Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Neurology
|
May 11, 2016
Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry
Teresinha Evangelista, Libby Wood, Roberto Fernandez-Torron, et al.
Neuromuscular Disorders : NMD
|
March 5, 2026
Framing childhood-onset facioscapulohumeral dystrophy: from first symptoms to future trials
Jildou N Dijkstra, Corrie E Erasmus, Pierre Laurian, et al.
Journal of Neuromuscular Diseases
|
January 8, 2024
Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great Britain
Nikki Cornell, Anne-Marie Childs, Elizabeth Wraige, et al.
Acta Neuropathologica Communications
|
August 29, 2019
Clinical, histological, and genetic characterization of PYROXD1-related myopathy
Xavière Lornage, Vanessa Schartner, Inès Balbueno, et al.
BMJ Open
|
December 22, 2018
Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study
John P Bourke, Gillian Watson, Francesco Muntoni, et al.
Muscle & Nerve
|
October 21, 2017
Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy
Germán Morís, Libby Wood, Roberto FernáNdez-Torrón, et al.
Neuromuscular Disorders : NMD
|
August 23, 2018
ECEL1 gene related contractural syndrome: Long-term follow-up and update on clinical and pathological aspects
Urielle Ullmann, Luigi D'Argenzio, Shrey Mathur, et al.
Pilot and Feasibility Studies
|
March 31, 2017
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
Daniel Hind, James Parkin, Victoria Whitworth, et al.
Health Technology Assessment (Winchester, England)
|
June 20, 2017
Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
Daniel Hind, James Parkin, Victoria Whitworth, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 10, 2024
Loss of Function of the Cytoplasmic Fe-S Assembly Protein CIAO1 Causes a Neuromuscular Disorder with Compromise of Nucleocytoplasmic Fe-S Enzymes
Nunziata Maio, Rotem Orbach, Irina Zaharieva, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Neurology
|
May 11, 2016
Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry
Teresinha Evangelista, Libby Wood, Roberto Fernandez-Torron, et al.
Neuromuscular Disorders : NMD
|
March 5, 2026
Framing childhood-onset facioscapulohumeral dystrophy: from first symptoms to future trials
Jildou N Dijkstra, Corrie E Erasmus, Pierre Laurian, et al.
Journal of Neuromuscular Diseases
|
January 8, 2024
Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great Britain
Nikki Cornell, Anne-Marie Childs, Elizabeth Wraige, et al.
Acta Neuropathologica Communications
|
August 29, 2019
Clinical, histological, and genetic characterization of PYROXD1-related myopathy
Xavière Lornage, Vanessa Schartner, Inès Balbueno, et al.
BMJ Open
|
December 22, 2018
Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study
John P Bourke, Gillian Watson, Francesco Muntoni, et al.
Muscle & Nerve
|
October 21, 2017
Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy
Germán Morís, Libby Wood, Roberto FernáNdez-Torrón, et al.
Neuromuscular Disorders : NMD
|
August 23, 2018
ECEL1 gene related contractural syndrome: Long-term follow-up and update on clinical and pathological aspects
Urielle Ullmann, Luigi D'Argenzio, Shrey Mathur, et al.
Pilot and Feasibility Studies
|
March 31, 2017
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
Daniel Hind, James Parkin, Victoria Whitworth, et al.
Health Technology Assessment (Winchester, England)
|
June 20, 2017
Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
Daniel Hind, James Parkin, Victoria Whitworth, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 10, 2024
Loss of Function of the Cytoplasmic Fe-S Assembly Protein CIAO1 Causes a Neuromuscular Disorder with Compromise of Nucleocytoplasmic Fe-S Enzymes
Nunziata Maio, Rotem Orbach, Irina Zaharieva, et al.
Page
of 4